Changes in renal function and occurrence of contrast-induced nephropathy after percutaneous coronary interventions in patients with atrial fibrillation treated with non-vitamin K oral anticoagulants or warfarin

机译：非维生素K口服抗凝剂或华法令治疗的房颤患者经皮冠状动脉介入治疗后肾功能的变化和造影剂诱发的肾病的发生

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

IntroductionPatients with atrial fibrillation (AF) receiving non-vitamin K oral anticoagulants (NOAC) have a slower decline in renal function than those taking warfarin. Moreover, a warfarin-related nephropathy has been described.

机译：简介接受非维生素K口服抗凝剂（NOAC）的房颤患者（AF）的肾功能下降速度比服用华法林的患者慢。此外，已经描述了华法林相关的肾病。

著录项

期刊名称 Postpy w Kardiologii Interwencyjnej = Advances in Interventional Cardiology
作者
Rocco A. Montone; Giampaolo Niccoli; Vincenzo Tufaro; Silvia Minelli; Michele Russo; Federico Vergni; Luigi Sommariva; Francesco Pelliccia; Francesco Bedogni; Filippo Crea;
展开▼
作者单位

展开▼
年(卷),期 2019(15),1
年度 2019
页码 59–67
总页数 9
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
percutaneous coronary intervention warfarin atrial fibrillation non-vitamin K oral anticoagulants contrast-induced nephropathy;

机译：经皮冠状动脉介入治疗;华法令;心房颤动;非维生素K口服抗凝剂;对比剂诱发的肾病;

相似文献

外文文献
中文文献
专利

1. Changes in renal function and occurrence of contrast-induced nephropathy after percutaneous coronary interventions in patients with atrial fibrillation treated with non-vitamin K oral anticoagulants or warfarin [J] . Rocco A. Montone, Giampaolo Niccoli, Vincenzo Tufaro, Advances in Interventional Cardiology: Postepy w Kardiologii Interwencyjnej . 2019,第1期

机译：经非维生素K口服抗凝剂或华法林治疗的房颤患者经皮冠状动脉介入治疗后肾功能的变化和造影剂诱发的肾病的发生
2. Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]) [J] . Steinberg Benjamin A., Simon DaJuanicia N., Thomas Laine, The American Journal of Cardiology . 2017,第10期

机译：用非维生素K拮抗剂口服抗凝剂治疗心房颤动患者重大出血的管理与临床实践中的华法林（来自结果登记处的II期，用于更好地了解心房颤动的信息[轨道-AF II]）
3. Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation with Coronary or Peripheral Artery Disease [J] . Hao Zhang, Zhengbiao Xue, Dongqian Yi, International heart journal . 2020,第2期

机译：非维生素K拮抗剂口腔抗凝血剂与患有冠状动脉或外周血动脉疾病的心房颤动患者的Warfarin
4. Impact of Renal Insufficiency on 30-Day Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention [C] . Sakai K., Tosaka A., Soga Y., World Congress on Heart Disease. . 2013

机译：肾功能不全对初级经皮冠状动脉干预治疗的ST段升高心肌梗死患者30天后的影响
5. Switching from Vitamin K Antagonists to Non-vitamin K Oral Anticoagulants, Drug-Drug Interactions, and Health Outcomes among Working-Age Adults with Atrial Fibrillation [D] . Feng, Xue. 2018

机译：从维生素K拮抗剂切换到非维生素K口服抗凝剂，药物 - 药物相互作用，以及具有心房颤动的工作年龄成年人之间的健康状况
6. Longitudinal Patterns in Antithrombotic Therapy in Patients with Atrial Fibrillation after Percutaneous Coronary Intervention in the Non-Vitamin K Oral Anticoagulant Era: A Nationwide Population-Based Study [O] . Jiesuck Park, Jin-Hyung Jung, Eue-Keun Choi, 2021

机译：在非维生素K口服抗凝品时期经皮冠状动脉介入后心房颤动患者抗血栓形成患者的纵向模式：全国范围的群体研究
7. 4367Comparison of non-vitamin K antagonist oral anticoagulants and warfarin on clinical outcomes in atrial fibrillation patients presenting myocardial infarction with percutaneous coronary intervention [O] . K H Lee, H W Park, H K Jeong, 2018

机译：非维生素K拮抗剂口腔抗凝剂和华法林对临床结果的4367比较患有经皮冠状动脉介入的心房颤动患者临床结果

Changes in renal function and occurrence of contrast-induced nephropathy after percutaneous coronary interventions in patients with atrial fibrillation treated with non-vitamin K oral anticoagulants or warfarin

摘要

著录项

相似文献

相关主题

期刊订阅